Cart
sales@molnova.com
Perifosine
CAS No. 157716-52-4
Perifosine ( KRX-0401;NSC 639966;D-21266;KRX 0401;KRX0401;D21266;D 21266 )
Catalog No. M12254 CAS No. 157716-52-4
A oral bioavailable alkylphospholipid that displays significant antiproliferative activity in vitro and in vivo in several human tumor model; acts as an Akt inhibitor and a PI3K inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 57 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 147 | In Stock |
|
| 50MG | 267 | In Stock |
|
| 100MG | 421 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePerifosine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA oral bioavailable alkylphospholipid that displays significant antiproliferative activity in vitro and in vivo in several human tumor model; acts as an Akt inhibitor and a PI3K inhibitor.
-
DescriptionA oral bioavailable alkylphospholipid that displays significant antiproliferative activity in vitro and in vivo in several human tumor model; acts as an Akt inhibitor and a PI3K inhibitor, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway; enhances apoptosis and inhibits the growth of xenografts in nude mice combined with a lysosomal inhibitor.Brain Cancer Phase 2 Clinical
-
SynonymsKRX-0401;NSC 639966;D-21266;KRX 0401;KRX0401;D21266;D 21266
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorAkt
-
Research AreaCancer
-
IndicationBrain Cancer
Chemical Information
-
CAS Number157716-52-4
-
Formula Weight461.66
-
Molecular FormulaC25H52NO4P
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=P(OC1CC[N+](C)(C)CC1)([O-])OCCCCCCCCCCCCCCCCCC
-
Chemical NamePiperidinium, 4-[[hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethyl-, inner salt
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kondapaka SB, et al. Mol Cancer Ther. 2003 Nov;2(11):1093-103.
2. Patel V, et al. Cancer Res. 2002 Mar 1;62(5):1401-9.
3. Becher OJ, et al. Cancer Res. 2010 Mar 15;70(6):2548-57.
2. Patel V, et al. Cancer Res. 2002 Mar 1;62(5):1401-9.
3. Becher OJ, et al. Cancer Res. 2010 Mar 15;70(6):2548-57.
molnova catalog
related products
-
Afuresertib
A potent, selective, ATP-competitive pan-AKT inhibitor with biochemical IC50 of 0.08/2/2.6 nM for AKT1/2/3.
-
AKT-I-1
AKT-I-1 is a selective and reversible inhibitor of Akt1.
-
A-674563
A-674563 is a potent, selective and orally available AKT inhibitor with Ki of 11 nM (Akt1).
